UNSPSC 51322202: Dalvastatin

This classification denotes an anti-lipidemic agent with the molecular formula C24H31FO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ZWE0X0IG9D, chemically known as 2h-pyran-2-one, tetrahydro-6-(2-(2-(4-fluoro-3-methylphenyl)-4,4,6,6-tetramethyl-1-cyclohexen-1-yl)ethenyl)-4-hydroxy-, (4r-(4-alpha,6-beta(e)))- but generally known as dalvastatin, which bears US NIH Compound Identifier 6436001. European Medicines Agency schedules Dalvastatin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06894MIG.

UNSPSC 51322202 Dalvastatin is a Commodity code that covers specific pharmaceutical preparations used in emergency medical care, though recent state and local solicitation activity under this code shows demand for a broader mix of advanced life support medications rather than dalvastatin alone. State and local governments procure these medications through their fire rescue, emergency medical services, and public health departments for field administration by paramedics and emergency responders. Issuing bodies include city purchasing departments and county-level emergency services agencies acting on behalf of fire rescue and EMS operations.

The City of Tampa's Purchasing Department posted an IFB (Bid No. 26-P-00188) on April 24, 2026, for Advanced Life Support Medications to supply Tampa Fire Rescue in Hillsborough County, Florida, with response due April 8, 2026. The solicitation specified four medication line items—Labetalol HCI, Epinephrine, Adenosine, and Diltiazem—totaling approximately $40,000 in estimated contract value, with a one-year initial term and two optional one-year renewals. The bid included a Small Local Business Enterprise sheltered-market designation with a 5 percent discount capped at $10,000. This is the primary recent activity visible under the code; the geographic spread is limited to Florida based on available records.